Clinical Trial Update: Coronary Flow Reserve Changes After Semaglutide Treatment

View source ↗

Summary

A completed clinical trial reported changes in coronary flow reserve following semaglutide treatment in both diabetic and non-diabetic patients with obesity or …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Obesity

Drugs mentioned

• semaglutide (semaglutide)

Snippet

Sponsor: Ekrem Bilal Karaayvaz | Conditions: The Study Focused on the Vascular Effects of Semaglutide in Both Diabetic and Non-diabetic Patients, Obesity &Amp; Overweight | Status: COMPLETED